Adipocytes properties and crosstalk with immune system in obesity-related inflammation.
Obesity is a condition likely associated with several dysmetabolic conditions or worsening of cardiovascular and other chronic disturbances. A key role in this mechanism seem to be played by the onset of low-grade systemic inflammation, highlighting the importance of the interplay between adipocytes and immune system cells. Adipocytes express a complex and highly adaptive biological profile being capable to selectively activate different metabolic pathways in order to respond to environmental stimuli. It has been demonstrated how adipocytes, under appropriate stimulation, can easily differentiate and de-differentiate thereby converting themselves into different phenotypes according to metabolic necessities. Although underlying mechanisms are not fully understood, growing in adipocyte size and the inability of storing triglycerides under overfeeding conditions seem to be crucial for the switching to a dysfunctional metabolic profile, which is characterized by inflammatory and apoptotic pathways activation, and by the shifting to pro-inflammatory adipokines secretion. In obesity, changes in adipokines secretion along with adipocyte deregulation and fatty acids release into circulation contribute to maintain immune cells activation as well as their infiltration into regulatory organs. Over the well-established role of macrophages, recent findings suggest the involvement of new classes of immune cells such as T regulatory lymphocytes and neutrophils in the development inflammation and multi systemic worsening. Deeply understanding the pathways of adipocyte regulation and the de-differentiation process could be extremely useful for developing novel strategies aimed at curbing obesity-related inflammation and related metabolic disorders.
Clinica di Ematologia, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy.
Giulia
G
Maurizi
Dipartimento di Sanità Pubblica, Medicina Sperimentale e Forense, Unità di Scienza dell'Alimentazione, Università degli studi di Pavia, Pavia, Italy.
Lucio
L
Della Guardia
Chirurgia d'Urgenza e del Trauma, Azienda Ospedaliera Universitaria-Ospedali Riuniti di Ancona, Ancona, Italy.
Angela
A
Maurizi
Clinica di Ematologia, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy.
Antonella
http://orcid.org/0000-0002-4221-4125
A
Poloni
D017667:Adipocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D050156:Adipogenesis; D054392:Adipokines / Q000378:metabolism; D000818:Animals; D017209:Apoptosis; D002450:Cell Communication; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D007107:Immune System / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D007249:Inflammation / Q000209:etiology* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D018836:Inflammation Mediators / Q000378:metabolism; D050356:Lipid Metabolism; D009765:Obesity / Q000150:complications* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D010641:Phenotype; D015398:Signal Transduction
D054392:Adipokines; D016207:Cytokines; D018836:Inflammation Mediators
adipocytes; adipokines; inflammation; liposecretion; obesity